Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / cs
-
Total 13F shares
-
202,682
-
Share change
-
-11,182
-
Total reported value
-
$81,276
-
Price per share
-
$0.40
-
Number of holders
-
13
-
Value change
-
-$38,447
-
Number of buys
-
6
-
Number of sells
-
8
Institutional Holders of HELIUS MEDICAL TECHNOLOGIES, INC. - cs (HSDT) as of Q1 2025
As of 31 Mar 2025,
HELIUS MEDICAL TECHNOLOGIES, INC. - cs (HSDT) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
202,682 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, Grant Private Wealth Management Inc, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, VANGUARD GROUP INC, IFP Advisors, Inc, Tower Research Capital LLC (TRC), SBI Securities Co., Ltd., CoreCap Advisors, LLC, and American Capital Advisory, LLC.
This page lists
13
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.